Navigation Links
Ceregene Appoints Joao Siffert, M.D. to the Position of Chief Medical Officer
Date:10/2/2007

of Neurology and Psychiatry. He holds an M.D. degree from the University of Sao Paulo School of Medicine as well as an MBA degree from Columbia University Business School.

"I am pleased to join Ceregene at this particular juncture in the company's history, as the company has accomplished a lot in its clinical programs for Parkinson's and Alzheimer's disease, and I look forward to help steer these promising therapies through later stage clinical development," said Dr. Siffert. "I have reviewed Ceregene's nonclinical and clinical data to date, and I am particularly excited by the potential that CERE-120 and CERE-110 show to not only reduce the symptoms of Parkinson's disease and Alzheimer's disease, respectively, but also to treat the underlying disease process."

"Joao's breadth of experience in developing novel neurological products will be invaluable to Ceregene as our programs continue to mature," stated Dr. Bartus. "I personally look forward to working with Joao to refine and execute our clinical and regulatory strategies and am pleased to welcome someone with such experience and success to help lead our clinical programs as a key member of our executive team."

About Ceregene

Ceregene, Inc. is a San Diego-based biotechnology company focused on the delivery of nervous system growth factors for the treatment of neurodegenerative disorders using gene delivery. Ceregene's clinical programs include CERE-110, an AAV2 based vector expressing nerve growth factor that is currently in Phase 1/2 studies for the treatment of Alzheimer's disease, and CERE-120 (AAV2-Neurturin) currently in a controlled Phase 2 study for Parkinson's disease. CERE-130 and CERE-140 are in preclinical development for ALS (Lou Gehrig's disease) and ocular disorders, respectively. Ceregene was launched in January 2001, and the company's investors include Alta Partners, MPM Capital, Investor Growth Capital and Cell Genesys (Nasdaq:

SOURCE Ceregene
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Sharon Ethanol appoints operations director
2. Kyron appoints former AMA chairman to board
3. Brady appoints GE efficiency expert as CTO
4. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
5. Johnson Controls appoints Roell to head EOC
6. SecurePipe appoints two senior execs
7. Milwaukees PointOne appoints new president and CEO
8. Third Wave appoints new chairman
9. Midwest Venture Summit disappoints; Cato grades Midwest governors
10. Sonic Foundry appoints Engineering Dean and Cometa CEO to Board of Directors
11. TeraMEDICA Appoints Prekop as New President
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... Pfenex Inc. (NYSE MKT: PFNX), a ... biosimilar therapeutics including high value and difficult to ... 2015 financial results will be released on Thursday, ... 8:30 am Eastern Time, Pfenex management will host ... and provide a business update. A press release outlining ...
(Date:5/1/2015)... , May 1, 2015 Albany Molecular ... William S. Marth , AMRI,s President and Chief ... Merrill Lynch 2015 Health Care Conference on Wednesday, May ... live audio webcast of the presentation can be accessed ... The webcast will be archived for ...
(Date:4/30/2015)... -- Roka Bioscience, Inc. (NASDAQ: ROKA ), a molecular ... the detection of foodborne pathogens, announced plans to release ... on May 7, 2015 after the close of the ... a conference call at 4:30 p.m. Eastern Time on ... results. During the conference call, material information concerning the ...
(Date:4/30/2015)... Nitto Avecia, a leading biotechnology ... capacity and production capability to serve biotechnology pharmaceutical ... service fulfillment continues to drive Nitto Avecia to ... capacities. , In Fall 2014, Nitto ... equipment at its Milford, MA facility, which is ...
Breaking Biology Technology:Pfenex To Report First Quarter 2015 Results and Provide Business Update on Thursday, May 14, 2015 2AMRI to Present at the Bank of America Merrill Lynch 2015 Health Care Conference 2Roka Bioscience to Report First Quarter 2015 Financial Results On May 7, 2015 2Biotechnology Manufacturer Nitto Avecia Expands Capacity to Meet Client Demand 2
... /PRNewswire-FirstCall/-- MINRAD,International, Inc. (Amex: BUF ) announced today that ... quarter 2008 financial results,on Tuesday, May 13, 2008 at 4:30 ... to the call on Tuesday, May 13, 2008., The ... (866) 866-1333.,The international call in number is (404) 260-1421., ...
... 8 BioSpace, the world,s leading,online bioscience ... company, unveiled,this morning the 2008 Bio NC(TM) ... Carolina., (Photo: http://www.newscom.com/cgi-bin/prnh/20080508/CLTH087 ), ... This unique campaign highlights the biotechnology, pharmaceutical ...
... ("AIT"),announced today that the company,s Biochemimarker(TM) Discovery Products,will ... from autistic children,for metabolic biochemical assessment when they ... constructed at The Children,s Institute,in Pittsburgh, PA. Scott ... will lead a team of scientists for this ...
Cached Biology Technology:MINRAD International, Inc. to Discuss 2008 First Quarter Financial Results on Tuesday, May 13, 2008 2BioSpace Launches 6th Edition of Bio NC(TM) Hotbed Campaign 2Applied Isotope Technologies will Exclusively Supply Biochemimarker(TM) Discovery Products for a Unique Pilot Study on Autism 2
(Date:4/8/2015)... 2015  Infinisource, a leading provider of SaaS-based Human ... a leading supplier of biometric identification and security ... most advanced biometrically-enabled time clock, the companies announced ... is setting a bold, new standard for the ... small and mid-size employer. When connected to the ...
(Date:4/2/2015)... In the current eight ... the strongest competitors, showing outstanding performance in recognition ... is capable of a throughput of 5.000.000 fingerprints ... be ten times faster than most competitors and ...      (Photo: http://photos.prnewswire.com/prnh/20150402/738673-a ) , ...
(Date:4/2/2015)... , April 2, 2015 According ... 2015 attributed to somewhat higher than 125 MSEK. This ... year-end report 2014 that revenues for Q1 2015 would ... company reported for Q4 2014. The operating result for ... negative. The complete interim report will as previously communicated ...
Breaking Biology News(10 mins):iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3Fingerprint Cards Revises Revenues for Q1 2015 2
... emit deadly venom from tentacles that can reach ten feet in ... been of interest to scientists and to the public. Yet little ... the animal tree of life. In a paper published November ... researchers Allen Collins, Bastian Bentlage and Cheryl Lewis Ames of the ...
... Scientists in China are reporting discovery of unusual liver ... long-standing mystery of why the hepatitis B virus (HBV) sexually ... been published online in ACS, Journal of Proteome Research ... and colleagues note that chronic hepatitis B seems to progress ...
... A new generation of "green" automobile tires that can ... their way through the research pipeline. The new tires could ... a car,s fuel economy. That,s the topic of the cover ... (C&EN) ACS, weekly newsmagazine. C&EN Senior Editor Alexander ...
Cached Biology News:Scientists unravel evolution of highly toxic box jellyfish 2Scientists unravel evolution of highly toxic box jellyfish 3
... The DMW143 taken from the SMZ line ... environments of production and testing. It is available ... base (FBGG) or a space-saving compact base (N2GG). ... computer, TV and a projector all at the ...
... Odyssey images are easily imported for data analysis , ... ... , Extensive background and signal options to optimize, ... results , ...
This is a PYREX replacement Allihn condenser with a 34/45 inner joint on the bottom for the No. CLS3840-S 125mL extractor system. The tubulation O.D. on the condenser is 10mm....
... unique human proteins on a 1x3 ... a cross section of all cellular ... high-quality results. Additional control proteins and ... validity and reproducibility., ,UNIchip protein microarrays ...
Biology Products: